glp 1 and inflammation GLP-1 Receptor Agonists Reduce GLP-1 drugs calm inflammation beyond

Endogenous hyperinsulinemia may cause weight gain and obesity [30], and treatment with insulin causes substantial weight gain, and may even increase cardiovascular risk [31]

It mimics the incretin hormone GLP-1 to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through central pathways

Talking to Your Provider If youre currently breastfeeding and eager to start GLP-1 treatment, the most important step is having an honest conversation with your prescriber about your timeline

Patients using GLP-1 for obesity treatment have reported an average weight loss of 15% or more of their body weight within a year

Semaglutide (Wegovy, Ozempic) is the second most effective at 10-15% average weight loss